{
"slug": "The-Role-of-IgE-in-Allergic-and-Chronic-Sinusitis--Mechanisms--Treatments--and-Impact-on--5578822607ff",
"title": "The Role of IgE in Allergic and Chronic Sinusitis: Mechanisms, Treatments, and Impact on…",
"subtitle": "An allergy occurs when the immune system overreacts to harmless substances (allergens), driven by Immunoglobulin E (IgE). IgE triggers…",
"excerpt": "An allergy occurs when the immune system overreacts to harmless substances (allergens), driven by Immunoglobulin E (IgE). IgE triggers…",
"date": "2025-05-23",
"tags": [
"Health"
],
"readingTime": "7 min",
"url": "https://medium.com/@mobinshaterian/the-role-of-ige-in-allergic-and-chronic-sinusitis-mechanisms-treatments-and-impact-on-5578822607ff",
"hero": "https://cdn-images-1.medium.com/max/800/1*Hp8I7OMEpnAyWQoBCUpVPA.jpeg",
"content": [
{
"type": "heading",
"level": 2,
"text": "The Role of IgE in Allergic and Chronic Sinusitis: Mechanisms, Treatments, and Impact on Respiratory Health"
},
{
"type": "paragraph",
"html": "An allergy occurs when the immune system overreacts to harmless substances (allergens), driven by Immunoglobulin E (IgE). IgE triggers allergic responses by binding to mast cells and basophils, releasing inflammatory chemicals like histamine. In allergic rhinosinusitis, this causes symptoms like sneezing and congestion, while chronic rhinosinusitis with nasal polyps (CRSwNP) involves persistent IgE-mediated inflammation, eosinophil recruitment, and polyp formation. Elevated local IgE levels correlate with disease severity, making anti-IgE therapies (e.g., omalizumab) effectively reduce polyps and symptoms."
},
{
"type": "image",
"src": "https://cdn-images-1.medium.com/max/800/1*Hp8I7OMEpnAyWQoBCUpVPA.jpeg",
"alt": "The Role of IgE in Allergic and Chronic Sinusitis: Mechanisms, Treatments, and Impact on…",
"caption": "",
"width": 1024,
"height": 1024
},
{
"type": "paragraph",
"html": "Allergen immunotherapy (AIT) shifts immune responses from IgE to IgG4, reducing IgE levels over time. Corticosteroids suppress cytokines like IL-4 and IL-13, indirectly lowering IgE production. IgE contributes to asthma and COPD in bronchial diseases by exacerbating inflammation, mucus production, and airway remodeling."
},
{
"type": "paragraph",
"html": "Endoscopic sinus surgery (ESS) reduces recurrent sinusitis and antibiotic use by clearing sinus blockages and infections. Studies suggest ESS may also improve lower-airway conditions like asthma and COPD by eliminating sinus reservoirs of inflammation, though evidence for bronchitis prevention remains observational. Overall, IgE is central to both upper and lower respiratory pathologies, with targeted therapies and surgery offering significant clinical benefits."
},
{
"type": "heading",
"level": 2,
"text": "What is an Allergy?"
},
{
"type": "paragraph",
"html": "An allergy is when your body’s immune system overreacts to something that is usually harmless, like pollen, dust, certain foods, or animal hair."
},
{
"type": "list",
"ordered": false,
"items": [
"These things are called allergens.",
"When someone has an allergy, their body treats these allergens like dangerous invaders (even though they’re not).",
"This can cause symptoms like sneezing, rashes, itchy eyes, trouble breathing, or even serious reactions like anaphylaxis."
]
},
{
"type": "heading",
"level": 2,
"text": "What is IgE?"
},
{
"type": "paragraph",
"html": "IgE stands for Immunoglobulin E. It is a special type of antibody your body makes."
},
{
"type": "list",
"ordered": false,
"items": [
"Antibodies are proteins that help fight germs.",
"But in allergies, IgE gets confused and reacts to harmless things like peanuts or pollen."
]
},
{
"type": "heading",
"level": 2,
"text": "Allergic Rhinosinusitis"
},
{
"type": "paragraph",
"html": "In allergic rhinosinusitis, IgE reacts to allergens (like pollen or dust) and causes quick symptoms such as sneezing and a stuffy nose by triggering the release of chemicals like histamine."
},
{
"type": "paragraph",
"html": "In chronic rhinosinusitis with nasal polyps (CRSwNP), the body produces IgE in the nose, which keeps attracting inflammatory cells (eosinophils). This leads to swelling and polyp growth in the sinuses and makes the disease worse."
},
{
"type": "paragraph",
"html": "Doctors can check IgE levels in blood or tissue to find out if someone has this “type 2” kind of inflammation. If they do, anti-IgE treatment (like omalizumab) can help shrink the polyps, open up the sinuses, and relieve symptoms."
},
{
"type": "heading",
"level": 2,
"text": "1. IgE in Allergic Rhinosinusitis"
},
{
"type": "list",
"ordered": false,
"items": [
"Type I hypersensitivity in the sinuses begins when inhaled allergens cross-link IgE on FcεRI receptors of mast cells and basophils, triggering degranulation and release of histamine, prostaglandins, and leukotrienes that cause mucosal swelling, mucus hypersecretion, and nasal obstruction Wikipedia.",
"Clinical manifestations include sneezing, rhinorrhea, itching, and congestion — symptoms identical to allergic rhinitis but extending into the paranasal sinuses when inflammation blocks sinus ostia, Wikipedia.",
"Local IgE production can occur within the nasal mucosa independent of serum levels, meaning patients with normal blood IgE may still have high sinonasal IgE and allergic symptoms, Wiley Online Library."
]
},
{
"type": "heading",
"level": 2,
"text": "2. IgE in Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)"
},
{
"type": "list",
"ordered": false,
"items": [
"Type-2 endotype: CRSwNP is characterized by T2 inflammation with high local IgE, IL-4, IL-5, and IL-13, leading to eosinophil‐predominant infiltrates and polyp growth, PubMedWiley Online Library.",
"Eosinophil migration: IgE directly promotes eosinophil chemotaxis into polyp tissue, amplifying inflammation and tissue remodeling, JAci OnlineScienceDirect.",
"Biomarkers: Elevated total or allergen-specific IgE in polyp tissue correlates with disease severity, polyp size, and recurrence risk after surgery. World Allergy Organization JournalDove Press."
]
},
{
"type": "image",
"src": "https://cdn-images-1.medium.com/max/800/1*6rn1tBjZwINqZgrdlhCKMA.jpeg",
"alt": "The Role of IgE in Allergic and Chronic Sinusitis: Mechanisms, Treatments, and Impact on…",
"caption": "",
"width": 1472,
"height": 832
},
{
"type": "heading",
"level": 2,
"text": "Allergen Immunotherapy"
},
{
"type": "heading",
"level": 2,
"text": "Mechanism"
},
{
"type": "paragraph",
"html": "Allergen immunotherapy (AIT) administers gradually increasing doses of the culprit allergen to promote immune tolerance by skewing responses from IgE toward IgG4 and regulatory T cells. Nature."
},
{
"type": "heading",
"level": 2,
"text": "IgE Dynamics"
},
{
"type": "paragraph",
"html": "AIT often causes a transient rise in specific IgE in the first months, followed by a sustained decline in both specific and, over longer courses, in total IgE PMC. Clinical studies report significant reductions in allergen-specific IgE titers after 1–3 years of subcutaneous or sublingual AIT PMC."
},
{
"type": "heading",
"level": 2,
"text": "Mechanisms of Corticosteroid Action on IgE"
},
{
"type": "list",
"ordered": false,
"items": [
"Cytokine suppression: Glucocorticoids down-regulate IL-4 and IL-13 production by Th2 cells, blocking the primary signals for B-cell IgE class switching, PMC.",
"Interference with pro-resolving mediators: Corticosteroids inhibit specialized pro-resolving lipid mediators (e.g., 17-HDHA, RvD1) that normally restrain IgE synthesis, leading to a paradoxical enhancement of epsilon germline transcription in B cells, PMCJCI Insight."
]
},
{
"type": "heading",
"level": 2,
"text": "IgE in Sinusitis"
},
{
"type": "heading",
"level": 3,
"text": "Local IgE Production and Type-2 Inflammation"
},
{
"type": "paragraph",
"html": "In CRSwNP, B cells within the sinonasal mucosa class-switch to produce IgE independently of serum levels, driving a self-sustaining type-2 environment rich in IL-4, IL-5, and IL-13 PubMedJAci Online. IgE bound to FcεRI on mast cells and basophils triggers degranulation — releasing histamine, leukotrienes, and prostaglandins — that leads to mucosal swelling, mucus hypersecretion, and blockage of sinus ostia. World Allergy Organization JournalDove Press."
},
{
"type": "heading",
"level": 3,
"text": "Eosinophil Recruitment and Polyp Formation"
},
{
"type": "paragraph",
"html": "IgE directly promotes eosinophil chemotaxis into sinonasal tissues, amplifying edema and facilitating polyp growth; baseline local IgE⁺ cell counts predict response to omalizumab in CRSwNP JAci OnlineScienceDirect. This IgE-eosinophil axis correlates strongly with disease severity, polyp size, and recurrence risk after surgery. Pulmonary chronicles, Science Direct."
},
{
"type": "heading",
"level": 2,
"text": "Therapeutic Targeting of IgE"
},
{
"type": "paragraph",
"html": "Omalizumab — an anti-IgE monoclonal antibody — binds free IgE, down-regulating FcεRI on effector cells and reducing local IgE-mediated inflammation, which translates into decreased polyp burden and improved sinus ventilation PubMedJAci Online. Clinical trials demonstrate symptom improvement irrespective of systemic atopic status, highlighting the pathogenic role of local IgE Dove PressMDPI."
},
{
"type": "heading",
"level": 2,
"text": "IgE-Mediated Pathways to Bronchial Disease"
},
{
"type": "heading",
"level": 2,
"text": "Allergic Bronchitis and Asthma"
},
{
"type": "paragraph",
"html": "IgE underlies bronchial hyperreactivity by sensitizing mast cells and basophils in the lower airways, where cross-linking by inhaled allergens provokes bronchoconstriction, mucus production, and cough characteristic of allergic bronchitis and asthma PMCJAci Online. Elevated serum IgE correlates with asthma severity and exacerbation frequency, PMCBioMed Central."
},
{
"type": "heading",
"level": 2,
"text": "Progression to Chronic Bronchitis and COPD Phenotypes"
},
{
"type": "paragraph",
"html": "In COPD, particularly in individuals with atopic sensitization, higher IgE levels are linked to more frequent exacerbations and accelerated lung-function decline, suggesting that IgE-driven inflammation contributes to chronic bronchitic phenotypes. BioMed Central Ann Allergy. Histologic studies of chronic bronchitis exacerbations reveal eosinophilic inflammation similar to asthma, implicating IgE pathways in airway remodeling and mucus hypersecretion. ScienceDirectERS Publications."
},
{
"type": "heading",
"level": 2,
"text": "Did endoscopic sinus surgery help reduce the risk of sinusitis and bronchitis?"
},
{
"type": "paragraph",
"html": "Below is a concise overview of the published evidence on whether endoscopic sinus surgery (ESS) reduces the risk of recurrent sinusitis and of lower-airway infections such as bronchitis."
},
{
"type": "heading",
"level": 2,
"text": "Impact on Recurrent Sinusitis and Antibiotic Utilization"
},
{
"type": "heading",
"level": 2,
"text": "Significant Reduction in Antibiotic Use"
},
{
"type": "list",
"ordered": false,
"items": [
"In a prospective cohort of 503 patients with chronic rhinosinusitis (CRS) or recurrent acute rhinosinusitis (RARS), ESS led to a 57.2% overall reduction in time on antibiotics, with 60.4% of patients reporting significantly less antibiotic use postoperatively (83.7% reduction in antibiotic days; p < 0.001). PubMed.",
"Those with and without nasal polyps, as well as RARS patients, all saw significant declines in antibiotic utilization (p < 0.001). PubMedPMC."
]
},
{
"type": "heading",
"level": 2,
"text": "Fewer Sinusitis Episodes Requiring Medical Therapy"
},
{
"type": "list",
"ordered": false,
"items": [
"Radiographic and clinical severity scores for sino-pulmonary disease decreased after ESS, with a parallel drop in courses of antibiotics for sino-pulmonary infections over a 4-year period when comparing two years pre- and post-ESS, JAci Online.",
"In head-to-head comparisons, postoperative ARS (acute rhinosinusitis) episode rates after balloon sinuplasty and ESS were similarly reduced, underscoring ESS’s durability in preventing acute sinus infections Wikipedia."
]
},
{
"type": "heading",
"level": 2,
"text": "Effects on Lower-Airway Disease (Asthma, COPD, Bronchitis)"
},
{
"type": "heading",
"level": 2,
"text": "Improvement in Asthma and COPD Symptom Scores"
},
{
"type": "list",
"ordered": false,
"items": [
"A small pilot study found ESS produced beneficial effects on both upper and lower airway status in CRS patients, regardless of lower-airway disease; symptom scores improved across the board.PMC.",
"In a prospective Iranian cohort (n=82; 45 asthma, 37 COPD), ESS significantly improved quality-of-life (SNOT-22) and asthma control (ACT) scores (p < 0.001), and improved COPD Assessment Test (CAT) scores (p < 0.001), although spirometry gains were seen only in asthmatics.PubMed."
]
},
{
"type": "heading",
"level": 2,
"text": "Indirect Inference on Bronchitis Risk"
},
{
"type": "list",
"ordered": false,
"items": [
"Chronic sinusitis is a known risk factor for bronchitis by serving as a bacterial reservoir; ESS removes these reservoirs, theoretically lowering bronchitic exacerbations, JAci Online.",
"Healthdirect states that long-term ESS outcomes include lasting relief in areas of chronic bronchitis and reduced infection susceptibility, although this is based on aggregated patient reports rather than controlled trials Nürnberg HNO."
]
},
{
"type": "heading",
"level": 2,
"text": "In conclusion"
},
{
"type": "paragraph",
"html": "Immunoglobulin E (IgE) plays a central role in the pathogenesis of both upper and lower respiratory tract diseases, including allergic rhinosinusitis, chronic rhinosinusitis with nasal polyps (CRSwNP), asthma, and chronic obstructive pulmonary disease (COPD). In allergic rhinosinusitis, IgE-mediated hypersensitivity reactions lead to symptoms such as sneezing and nasal congestion. In CRSwNP, local IgE production contributes to persistent type 2 inflammation, eosinophilic infiltration, and polyp formation, correlating with disease severity and recurrence risk. Anti-IgE therapies, such as omalizumab, have demonstrated efficacy in reducing polyp burden and improving symptoms in CRSwNP patients, regardless of systemic atopic status."
},
{
"type": "paragraph",
"html": "Elevated IgE levels are associated with increased asthma severity, exacerbation frequency, and airway remodeling in the lower airways. In COPD, higher total IgE levels have been linked to more frequent exacerbations and accelerated lung function decline, particularly in men. These findings suggest that IgE-mediated pathways contribute significantly to the pathophysiology of both asthma and COPD.PubMed Central"
},
{
"type": "paragraph",
"html": "Endoscopic sinus surgery (ESS) has been shown to provide substantial benefits in managing chronic rhinosinusitis and its impact on lower airway diseases. ESS effectively reduces sinus blockages, decreases the frequency of sinus infections, and lowers antibiotic usage. Moreover, ESS has been associated with improvements in asthma and COPD symptoms, likely due to the reduction of sinonasal inflammation and its downstream effects on the lower airways.MDPI"
},
{
"type": "paragraph",
"html": "Overall, targeting IgE through pharmacological interventions and addressing sinonasal inflammation via surgical means offer complementary strategies to alleviate symptoms and improve quality of life in patients with IgE-mediated respiratory conditions."
}
]
}